Cite
MLA Citation
S.‐M. Jin et al.. “Anagliptin and sitagliptin as add‐ons to metformin for patients with type 2 diabetes: a 24‐week, multicentre, randomized, double‐blind, active‐controlled, phase III clinical trial with a 28‐week extension.” Diabetes, obesity & metabolism, vol. 17, no. 5, n.d., pp. 511–515. http://access.bl.uk/ark:/81055/vdc_100025023950.0x000027